Tracking early autoimmune disease by bioluminescent imaging of NF-kB activation reveals pathology in multiple organ systems

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1358-1367

  Zangani, Michael ^a   Carlsen, Harald ^b   Kielland, Anders ^b   Os, Audun ^a   Hauglin, Harald ^b   Blomhoff, Rune ^b   Munthe, Ludvig A ^a,c   Bogen, Bjarne ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b University Ofoslo   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTOANTIBODY; GLIADIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN IDIOTYPE; LUCIFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; T LYMPHOCYTE RECEPTOR; AUTOANTIGEN; DIAGNOSTIC AGENT; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHOTOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOLUMINESCENCE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LYMPHOID ORGAN; MACROPHAGE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SKIN DEFECT; SMALL INTESTINE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; BLOOD; ENZYME ACTIVATION; GENETICS; IMMUNOLOGY; LUMINESCENCE; METABOLISM; METHODOLOGY; PHYSIOLOGY; REPORTER GENE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; ENZYME ACTIVATION; GENES, REPORTER; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MACROPHAGES; MICE; MICE, TRANSGENIC; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 65349100490     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080700     Document Type: Article

References (44)

1. Williams WM, Staines NA, Muller S, Isenberg DA: Human T cell responses to autoantibody variable region peptides. Lupus 1995, 4:464-471
2. Dayan M, Segal R, SthoegerZ, Waisman A, Brosh N, Elkayam O, Eilat E, Fridkin M, Mozes E: Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. J Clin Immunol 2000, 20:187-194
3. van Schooten WC, Devereux D, Ho CH, Quan J, Aguilar BA, Rust CJ: Joint-derived T cells in rheumatoid arthritis react with self-immuno- globulin heavy chains or immunoglobulin-binding proteins that copu- rify with immunoglobulin. Eur J Immunol 1994, 24:93-98
4. Holmoy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F: Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur J Immunol 2005, 35:1786-1794
5. Singh RR, Kumar V, Ebling FM, Southwood S, Sette A, Sercarz EE, Hahn BH: T cell determinants from autoantibodies to DNA can up- regulate autoimmunity in murine systemic lupus erythematosus. J Exp Med 1995, 181:2017-2027
6. Singh RR, Hahn BH: Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol Rev 1998, 164:201-208
7. Zhang X, Smith DS, Guth A, Wysocki LJ: A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J Immunol 2001, 166:1562-1571
8. Weiss S, Bogen B: B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex- restricted T cells. Proc Natl Acad Sci USA 1989, 86:282-286
9. Weiss S, Bogen B: MHC class II-restricted presentation of intracellular antigen. Cell 1991, 64:767-776
10. Bogen B, Dembic Z, Weiss S: Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J 1993, 12:357-363
11. Munthe LA, Kyte JA, Bogen B: Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-spe- cific CD4+ T cells in vivo. Eur J Immunol 1999, 29:4043-4052
12. Snyder CM, Zhang X, Wysocki LJ: Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J Immunol 2002, 168:3865-3873
13. Munthe LA, Os A, Zangani M, Bogen B: MHC-restricted Ig V region- driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J Immunol 2004, 172:7476-7484
14. Munthe LA, Corthay A, Os A, Zangani M, Bogen B: Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol 2005, 175:2391-2400
15. Snyder CM, Aviszus K, Heiser RA, Tonkin DR, Guth AM, and Wysocki LJ: Activation and tolerance in CD4+ T cells reactive to an immuno- globulin variable region. J Exp Med 2004, 200:1-11
16. Bogen B, Weiss S: Processing and presentation of idiotypes to MHC- restricted T cells. Int Rev Immunol 1993, 10:337-355
17. Bogen B, Jorgensen T, Hannestad K: T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur J Immunol 1985, 15:278-281
18. Bogen B, Malissen B, Haas W: Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 1986, 16:1373-1378
19. Eyerman MC, Zhang X, Wysocki LJ: T cell recognition and tolerance of antibody diversity. J Immunol 1996, 157:1037-1046
20. Karin M, Lin A: NF-[kappa]B at the crossroads of life and death. Nat Immunol 2002, 3:221-227
21. Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62
22. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-B activity. Ann Rev Immunol 2000, 18:621-663
23. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R: In vivo imaging of NF-[kappa]B activity. J Immunol 2002, 168:1441-1446
24. Bogen B, Weiss S: A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression. Eur J Immunol 1991, 21:2391-2395
25. Bogen B, Gleditsch L, Weiss S, Dembic Z: Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II. T cell receptor and CD4 surface molecule densities Eur J Immunol 1992, 22:703-709
26. Bogen B, Lauritzsen GF, Weiss S: A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones. Eur J Immunol 1990, 20:2359-2362
27. Nishinaka Y, Aramaki Y, Yoshida H, Masuya H, Sugawara T, Ichimori Y: A new sensitive chemiluminescence probe. L-012, for measuring the production of superoxide anion by cells. Biochem Biophys Res Commun 1993, 193:554-559
28. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978, 148:1198-1215
29. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT: Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005, 206:260-276
30. Cornelius EA: Protein-losing enteropathy in the graft-versus-host reaction. Transplantation 1970, 9:247-252
31. Vezys V, Lefrancois L: Inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 2002, 169:6677-6680
32. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH: Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999, 1:303-310
33. Hildebrandt IJ, Gambhir SS: Molecular imaging applications for immunology. Clin Immunol 2004, 111:210-224
34. Kim SB, Ozawa T, Watanabe S, Umezawa Y: High-throughput sensing and noninvasive imaging of protein nuclear transport by using reconstitution of split Renilla luciferase. Proc Natl Acad Sci USA 2004, 101:11542-11547
35. Weissleder R: A clearer vision for in vivo imaging. Nature Biotechnol 2001, 19:316-317
36. Ruland J, Mak TW: Transducing signals from antigen receptors to nuclear factor kappaB. Immunol Rev 2003, 193:93-100
37. Schneider P: The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 2005, 17:282-289
38. Bonizzi G, Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25:280-288
39. Enzler T, Bonizzi G, Silverman GJ, Otero DC, Widhopf GF, Anzelon- Mills A, Rickert RC, Karin M: Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 2006, 25:403-415
40. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607
41. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ: Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005, 202:321-331
42. Bianchi G, Montecucco F, Bertolotto M, Dallegri F, Ottonello L: Immune complexes induce monocyte survival through defined intracel- lular pathways. Ann NY Acad Sci 2007, 1095:209-219
43. Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002, 2:647-655
44. Fesus L, Szondy Z: Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 2005, 579:3297-3302